Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements - Summary of effect of restatement on the line items within consolidated Balance Sheet (Details)

v3.24.0.1
Restatement of Previously Issued Unaudited Interim Condensed Consolidated Financial Statements - Summary of effect of restatement on the line items within consolidated Balance Sheet (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Jan. 01, 2022
Dec. 31, 2021
Inventory $ 27,571   $ 29,800        
Current assets 50,647   50,622        
Total Assets 286,114   303,467        
Accrued and other current liabilities 93,998   74,036        
Current liabilities 133,300   92,566        
Total Liabilities 329,753   292,478        
Accumulated deficit (1,308,949)   (1,251,023)     $ (801,632)  
Total shareholders' deficit (43,639) $ (24,904) 10,989 $ 53,638 $ 70,976 (23,639) $ (23,639)
Total Liabilities and Shareholders' (Deficit) Equity 286,114   $ 303,467        
Previously reported              
Inventory 31,650            
Current assets 5,472            
Total Assets 290,193            
Accrued and other current liabilities 94,467            
Current liabilities 133,769            
Total Liabilities 330,222            
Accumulated deficit (1,305,339)         (800,390)  
Total shareholders' deficit (40,029)         $ (22,397)  
Total Liabilities and Shareholders' (Deficit) Equity 290,193            
Adjustment              
Inventory (4,079)            
Current assets (4,079)            
Total Assets (4,079)            
Accrued and other current liabilities (469)            
Current liabilities (469)            
Total Liabilities (469)            
Accumulated deficit (3,610)            
Total shareholders' deficit (3,610)            
Total Liabilities and Shareholders' (Deficit) Equity $ (4,079)